| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.06 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |